272.90
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
Praxis Precision Medicines (PRAX) Announces $575M Public Offerin - GuruFocus
Praxis Precision prices $575M stock offering at $260 - MSN
Praxis Precision Medicines prices public offering at $260 per share By Investing.com - Investing.com Australia
Praxis Precision Medicines prices public offering at $260 per share - Investing.com
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering - Yahoo Finance
Praxis Precision Medicines Announces Pricing of Public Offering of Common Stock at $260 Per Share - Quiver Quantitative
Praxis Precision Medicines reports preliminary $925 million in cash and securities By Investing.com - Investing.com South Africa
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis - Investing.com
Praxis Precision (PRAX) Announces Public Offering of Stock and W - GuruFocus
Praxis Precision Medicines reports preliminary $925 million in cash and securities - Investing.com
Praxis Precision Medicines slips after announcing equity offering plans - TradingView — Track All Markets
Praxis Precision Medicines announces proposed public offering By Investing.com - Investing.com India
Praxis Precision Medicines, Inc. Announces Proposed Public Offering - The Manila Times
Praxis Precision Medicines stock falls on proposed public offering By Investing.com - Investing.com UK
Praxis Precision Medicines, Inc. Announces Proposed Public Offering - Benzinga
Biotech developing CNS therapies plans new stock and warrant sale - Stock Titan
Praxis Precision Medicines stock rises as FDA grants breakthrough designation By Investing.com - Investing.com South Africa
Praxis Precision Medicines stock rises as FDA grants breakthrough designation - Investing.com Australia
Praxis Precision Medicines (PRAX) Gets a Buy from Chardan Capital - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Praxis Precision Medicines (PRAX) - The Globe and Mail
Praxis Precision Medicines stock gains as TD Cowen reiterates Buy on FDA breakthrough status - Investing.com Canada
Praxis: Priced For Perfection Heading Into 2026 (NASDAQ:PRAX) - Seeking Alpha
Praxis Precision Medicines stock falls on proposed public offering - Investing.com
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug - ts2.tech
Praxis Precision Medicines stock gets FDA boost as H.C. Wainwright maintains Buy - Investing.com Canada
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 3.4%Here's Why - MarketBeat
Praxis Precision (PRAX) Shares Drop Amid Market Movement - GuruFocus
Truist Securities reiterates Buy rating on Praxis Precision Medicines stock By Investing.com - Investing.com Canada
Truist Securities reiterates Buy rating on Praxis Precision Medicines stock - Investing.com India
Praxis Precision granted Breakthrough Therapy designation for Ulixacaltamide - Yahoo Finance
Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target - ts2.tech
Praxis rises on ulixacaltamide gaining Breakthrough Therapy status - MSN
Praxis Precision Medicines (PRAX) stock jumps 13% after FDA breakthrough designation for tremor drug - ts2.tech
Praxis Precision Medicines Stock Pre-Market (+12%) : FDA Breakthrough Therapy Designation for Ulixacaltamide - Trefis
Praxis Precision Medicines Stock Surges: What Drives the Wave? - StocksToTrade
Why Praxis Precision Medicines Stock Popped Today - Finviz
Praxis Precision Medicines: An Unexpected Surge? - timothysykes.com
These Stocks Moved the Most Today: Nvidia, Tesla, Newmont, DigitalBridge, Praxis Precision, Ultragenyx, and More - Barron's
Praxis Precision Medicines stock price target raised to $843 from $507 at BTIG By Investing.com - Investing.com South Africa
PRAX Stock Rises 13% in Premarket Trading - GuruFocus
Praxis Precision Medicines stock jumps after FDA grants breakthrough therapy designation By Investing.com - Investing.com South Africa
Nvidia, Tesla, Newmont, DigitalBridge, Praxis Precision, Ultragenyx, and More Movers - Barron's
Praxis Precision (PRAX) Shares Jump Over 14% - GuruFocus
Why Is Praxis Precision Medicines Stock Soaring Monday?Praxis Precision Medicine (NASDAQ:PRAX) - Benzinga
Praxis Precision Medicines stock jumps after FDA grants breakthrough therapy designation - Investing.com Nigeria
Praxis Precision (PRAX) Soars 14.7% on Market Uptick - GuruFocus
Praxis Precision Medicines (NASDAQ:PRAX) Sets New 12-Month HighTime to Buy? - MarketBeat
Praxis Precision Medicines (PRAX) Surges on FDA Breakthrough Des - GuruFocus
Jefferies reiterates Buy rating on Praxis Precision Medicines stock, cites FDA breakthrough designation - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):